<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>School of Agriculture and Life Sciences</title>
<link href="https://ir.unisa.ac.za/handle/10500/2726" rel="alternate"/>
<subtitle/>
<id>https://ir.unisa.ac.za/handle/10500/2726</id>
<updated>2026-11-20T11:04:20Z</updated>
<dc:date>2026-11-20T11:04:20Z</dc:date>
<entry>
<title>A Critical Review of Knowledge Gaps in PGPR-Based Enhancement of Medicinal Plant Production</title>
<link href="https://ir.unisa.ac.za/handle/10500/33239" rel="alternate"/>
<author>
<name>Adeleye, Oluwafunbi</name>
</author>
<author>
<name>Nogemane, Noluyolo</name>
</author>
<id>https://ir.unisa.ac.za/handle/10500/33239</id>
<updated>2026-11-19T08:48:18Z</updated>
<published>2026-10-28T00:00:00Z</published>
<summary type="text">A Critical Review of Knowledge Gaps in PGPR-Based Enhancement of Medicinal Plant Production
Adeleye, Oluwafunbi; Nogemane, Noluyolo
The therapeutic value of medicinal plants is attributed to the accumulation and constituents of secondary metabolites, such as phenolics, flavonoids, and terpenoids. Plant growth-promoting rhizobacteria (PGPR) provide an efficient approach to enhancing plant growth, development, health, and production. PGPR genera including Bacillus, Streptomyces, and Pseudomonas stimulate plant growth and development through a variety of mechanisms, including increased secondary metabolites, phytohormone production, and phytopathogen biocontrol, and thus promote sustainable agriculture. Africa is abundant in medicinal plants; however, the underrepresentation of PGPR research in Africa and the impact of specific environmental stress factors, such as drought, poor soil fertility, and climate variability, make PGPR-based sustainable cultivation strategies highly relevant. Medicinal plants are therapeutic in nature and, similar to crop plants, are susceptible to environmental stressors. Research optimizing production in both quality and quantity of these plants is essential, and hence, PGPR-mediated mechanisms that may enhance plant growth, stress tolerance, nutrient uptake, and sustainable cultivation practices are of interest. This review seeks to identify the gaps and limitations in recently published articles that focus on the application and influence of PGPR on the production of medicinal plants to inform future research on these rhizobacteria as well as optimize the use of PGPR. To collect relevant data, a variety of databases were used for literature search, such as Scopus, PubMed, ScienceDirect, and Web of Science. Several studies have demonstrated the beneficial effects of PGPR on the biosynthesis and accumulation of secondary metabolites in medicinal plants. The review of these studies revealed major limitations, including limited research conducted within Africa as well as a lack of validation of the bioactivity of the identified secondary metabolites. To address the limitations mentioned, it is important to conduct more continent-based research on medicinal plants with a focus on the application of PGPR in Africa.
</summary>
<dc:date>2026-10-28T00:00:00Z</dc:date>
</entry>
<entry>
<title>In vitro safety and renoprotective effects of psilocybe natalensis mushroom extracts in animal and human kidney cell lines</title>
<link href="https://ir.unisa.ac.za/handle/10500/33219" rel="alternate"/>
<author>
<name>Zwonaka, Mutavhatsindi</name>
</author>
<id>https://ir.unisa.ac.za/handle/10500/33219</id>
<updated>2026-11-09T11:56:00Z</updated>
<published>2026-01-01T00:00:00Z</published>
<summary type="text">In vitro safety and renoprotective effects of psilocybe natalensis mushroom extracts in animal and human kidney cell lines
Zwonaka, Mutavhatsindi
Background: Psilocybin containing mushrooms commonly referred to as “magic mushrooms” have been used historically for their mind healing and are increasingly being investigated for therapeutic applications, including major depressive disorder and potential anti-inflammatory properties. However, their safety and potential renoprotective effects in kidney disease remain unclear. Doxorubicin, is a widely used chemotherapeutic agent known to induce nephrotoxicity through oxidative stress, increase nitric oxide production, activate pro-inflammatory pathways and apoptosis.&#13;
Aim: This study aimed to investigate the safety and morphological effects, and potential renoprotective and anti-inflammatory effects of ethanol and hot-water extracts of Psilocybe natalensis (P. natalensis) mushroom in an in vitro model of doxorubicin-induced kidney cell injury and oxidative stress on Vero monkey kidney cells and human embryonic kidney (HEK-293) cells&#13;
Methods: Psilocybe natalensis “magic” mushrooms were harvested, dried, ground into a fine powder and extracted using hot-water and 70% ethanol. When confluent, Vero and HEK-293 kidney cells were treated with extracts for 48 hours to assess the cytotoxicity. Doxorubicin was used as a positive-control, and untreated cells were used as control. To test renoprotective effect, confluent Vero and HEK-293 cells were induced with 10 μM doxorubicin 45 minutes before and after treatment with different concentrations of P. natalensis water and ethanol extracts over 24 hours. Mitochondrial activity was measured using Mosmann's tetrazolium-based colorimetric (MTT) assay to assess percentage cell viability. Tumor necrosis factor-alpha (TNF-α) levels were measured in induced human HEK-293 kidney cells using ELISA. DX-10 were control cells induced with doxorubicin (10 μM); non-induced normal cells were normal cells that were neither induced nor treated with extracts; 40-DX were positive control cells that were induced and treated with 40 μM doxorubicin. Morphology on normal and doxorubicin-induced cells was assessed using phase-contrast microscopy and 100 μM lense (100x magnification).&#13;
Results: The LC₅₀ values indicated that the extracts were not cytotoxic compared to doxorubicin, with LC₅₀ values below 20 μg/mL in Vero and HEK-293 kidney cells. Human HEK-293 kidney cells had lower cytotoxicity (LC₅₀ &gt; 200 μg/mL) with both water and ethanol extracts, while Vero kidney cells had LC₅₀ of 199.50 ± 1.07 μg/mL with the ethanol extract. Doxorubicin inducing treatment (10 μM) significantly decreased percentage cell viability (p= 0.001) and increased nitrite oxide levels (p= 0.001) in both kidney cell types, with DX-40 significantly (p= 0.001) amplifying kidney cell injury effect even more. Hot-water and 70% ethanol extracts of P. natalensis enhanced %cell viability in doxorubicin-induced kidney cells in a dose-dependent manner, particularly when administered prior to doxorubicin exposure. Extracts also decreased induced-nitrite oxide levels dose-dependently, especially the 70% ethanol extract. Doxorubicin (10 μM) induced morphological changes, notably more severe in HEK-293 kidney cells. These effects of doxorubicin were not exacerbated on both kidney cells upon treatment with the mushroom extracts. Furthermore, the extracts reversed doxorubicin-induced TNF-α levels in a dose-dependent manner, with hot-water extracts showing more pronounced effects.&#13;
Conclusion: The study revealed that the hot-water and 70% ethanol extracts of Psilocybe natalensis mushroom were not toxic to the normal kidney cells used in the study and especially on human kidneys cells. The extracts protected against induced-kidney cell injury and did not worsen morphological alterations in kidney cells, while they also inhibited certain pro-inflammatory markers as indicated by induced-nitric oxide levels and TNF-α levels. Notably, hot-water and 70% ethanol extracts were found to be more effective, suggesting their potential for medicinal use in preventing kidney damage. Furthermore, the study aligns with previous research that has highlighted the antioxidant and anti-inflammatory properties of this psilocybin magic mushroom species, supporting its further investigation as a potential therapeutic agent for kidney function improvement in kidney disease conditions.
</summary>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Management practices and constraints of commercial poultry farms, and performance evaluation of sasso-c44 broilers fed on diets containing graded level dried blood rumen-content mixture</title>
<link href="https://ir.unisa.ac.za/handle/10500/33109" rel="alternate"/>
<author>
<name>Abdisa, Soresa Shuma</name>
</author>
<id>https://ir.unisa.ac.za/handle/10500/33109</id>
<updated>2026-10-07T05:56:03Z</updated>
<published>2026-03-01T00:00:00Z</published>
<summary type="text">Management practices and constraints of commercial poultry farms, and performance evaluation of sasso-c44 broilers fed on diets containing graded level dried blood rumen-content mixture
Abdisa, Soresa Shuma
This study was employed to assess the management practices and constraints of commercial poultry farms, and performance evaluation of Sasso-C44 broilers fed on diets containing graded level dried rumen content mixture. Data on farm management was collected using a semi structured questionnaire survey substantiated with a focus group discussion, and field observations. Data on management variables were processed using SPSS version 29, and Garret’s ranking technique. Two hundred day old Sasso C44 broiler chicks were placed randomly to five dietary treatments for the experimental study using a completely randomized design (CRD). Experimental rations during both the starter age (1 28 days) and finisher (29 56 days) were: T1,T2, T3,T4 and T5. The experimental treatments consisted five dietary groups formulated by replacing roasted soybean meal (RSBM) with dried blood rumen content Mixture (DBRCM) at different levels. Data were analyzed using SAS version 9.2. Intensive production systems account for 94.5% of the farms, and deep litter housing management account for 73.1% of the farms studied. Average flock size per farm in the study area was 734 birds, and Bovan Brown chicken breed were the dominant breed identified in this study. The disease prevalence assessments revealed a ruffled feathers (13.5%), loss of appetite (11.5%), and depression (11.5%), followed by weight loss (9.6%) and diarrhea (7.7%). Producers largely blamed management gaps (44.2%) or environmental factors (34.6%) with 21.2% citing a combination of both the primary drivers of outbreaks. Vaccination efforts focused mainly on fowl pox (51.9%) and Newcastle disease (40.4%), while fewer farms vaccinated against infectious bursal disease (7.7%); vaccination schedules typically followed recommendations from the chicks’ source farms. On the biosecurity front, most producers adopted basic protective measures: Accordingly, 73.1% used protective clothing, plastic boots, and hair covers, 30.4% of producers were using gloves, and 67.3% were maintaining footbaths at farm entrances. The standard vaccination schedule used were IBD vaccine on day 1, NCD vaccine on day 7, and boosters on days 14, 28, and 42 against other diseases. Feed intake and chicken growth responses varied slightly among treatments that average daily dry matter intake was in the range of 66.38 g at T4 to 71.60 g at T1 and T5; intake in T4 was lower than those at T1, T2, T3, and T5. Daily weight gain ranged from 29.8 to 31.5 g/bird with no significant statistical difference among treatments (P&gt;0.05). Feed&#13;
vii&#13;
conversion ratios ranged between 2.22 and 2.29 and were not different statistically among groups (P&gt;0.05). With the conclusion, DBRCM can replace up to 60% soybean meals in both starter and finisher diets for Sasso--C44 broilers with no negative impact on performance and survivability. Carcass evaluation revealed that edible carcass weights were between 1085g and 1178g, and the dressing percentage ranged from 52.3% to 57.79%. Dressing percentage and carcass weights remained comparable across treatments, reinforcing that DBRCM can replace up to 60% of soybean meals with a positive effect on growth performance and carcass quality. The economic analysis clearly indicated that birds under T3 and T4 had higher (P&lt;0.05) economic efficiencies than those under T1 and T5. In conclusion replacing RSBM with DBRCM up to a level of 60% in both starter and finisher diets seems to reduce feeding costs and improve economic efficiency due to its free availability and labor affordability without adverse effects on overall performance, feed conversion, or carcass characteristics in Sasso--C44 broilers
</summary>
<dc:date>2026-03-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Adoption of climate-smart agriculture practices by smallholder dairy farmers in Chipinge and Mutasa Districts of the Manicaland Province, Zimbabwe</title>
<link href="https://ir.unisa.ac.za/handle/10500/33107" rel="alternate"/>
<author>
<name>Chavhunduka, Tinashe</name>
</author>
<id>https://ir.unisa.ac.za/handle/10500/33107</id>
<updated>2026-09-30T10:23:52Z</updated>
<published>2026-08-14T00:00:00Z</published>
<summary type="text">Adoption of climate-smart agriculture practices by smallholder dairy farmers in Chipinge and Mutasa Districts of the Manicaland Province, Zimbabwe
Chavhunduka, Tinashe
Climate change poses significant constraints on smallholder dairy production systems in Zimbabwe, particularly in drought-prone regions such as Manicaland Province. This study analysed farmers’ perceptions of climate change and their influence on the adoption of Climate-Smart Agriculture (CSA) practices among smallholder dairy farmers in Chipinge and Mutasa districts. It further quantified the extent of adoption of adaptation- and mitigation-based CSA practices and identified socio-economic and institutional determinants shaping adoption decisions.&#13;
Guided by the Climate-Smart Agriculture framework of the Food and Agriculture Organization, which integrates productivity, resilience, and greenhouse gas mitigation objectives, the study employed a cross-sectional survey design. Primary data were collected from 154 smallholder dairy households using structured questionnaires. Descriptive statistics indicated that feed shortages (59.6%) and water scarcity (55.0%) were the most severe climate-related constraints, while 84.7% of respondents reported high awareness of the impacts of climate change on dairy production.&#13;
Inferential analysis revealed a statistically significant association between climate change perception and CSA adoption (χ², p &lt; 0.05), indicating that perception significantly shapes adoption behaviour. Binary logistic regression results showed that CSA adoption was significantly influenced by household size, education level, herd size, farming experience, access to finance, and perception of climate variability (p &lt; 0.05), confirming that both human capital and resource endowments are key adoption drivers. Further, multinomial logistic regression results demonstrated that district location significantly influenced farmers’ choice among adaptation-only, mitigation-only, and integrated CSA strategies (p &lt; 0.05), highlighting spatial heterogeneity in adoption behaviour. The model exhibited acceptable explanatory power, confirming robustness in predicting CSA adoption categories.&#13;
Despite high awareness levels (84.7%), CSA adoption remains constrained by structural socio-economic and institutional barriers. Adaptation practices are widely adopted but predominantly reactive and short-term coping strategies, while mitigation practices remain limited and are primarily motivated by productivity gains rather than by emission-reduction objectives. Agroforestry demonstrated moderate adoption (34%) and provided synergistic adaptation–mitigation benefits.&#13;
v&#13;
The study concludes that although smallholder dairy farmers exhibit adaptive capacity, their responses remain largely survivalist rather than transformative. Strengthening access to finance, enhancing extension services, and providing targeted incentives for mitigation-oriented technologies are critical to promoting integrated and sustainable climate-smart dairy systems in Zimbabwe
</summary>
<dc:date>2026-08-14T00:00:00Z</dc:date>
</entry>
</feed>
